Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
British Journal of Cancer
|
January 27, 2017
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion
Imam Waked, Sarah Berhane, Hidenori Toyoda, et al.
Nature Communications
|
December 23, 2022
Continuous cholinergic-dopaminergic updating in the nucleus accumbens underlies approaches to reward-predicting cues
Miguel Skirzewski, Oren Princz-Lebel, Liliana German-Castelan, et al.
Journal of Stem Cells & Regenerative Medicine
|
June 27, 2023
In Vivo Tumorigenicity of the 20q11.21 Amplicon in an Engraftment Model of hPSCs and Differentiated Liver Cells
Chris S Pridgeon, Shiva Seyed Forootan, Fang Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2014
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade
Philip J Johnson, Sarah Berhane, Chiaki Kagebayashi, et al.
British Journal of Cancer
|
February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
Natalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)
|
March 13, 2026
Dynamics in Circulating Proinflammatory Biomarkers for Prognostic Assessment of Patients With Advanced HCC - A Substudy From the SORAMIC Trial
Kerstin Schütte, Juozas Kupčinskas, Egidijus Morkunas, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 12, 2018
Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe
Muhammad Ahsan Javed, Georg Beyer, Nha Le, et al.
Journal of Hepatology
|
November 7, 2022
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study
Masatoshi Kudo, Richard S Finn, Shukui Qin, et al.
Cancers
|
September 13, 2025
UK Real-World Evidence of Using Durvalumab Plus Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer via an Early Access Scheme
Harry Daniels, Mona Hassan, Omer Babiker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2025
Addition of dendritic cell vaccination to conditioning cyclophosphamide and chemoembolisation in patients with hepatocellular carcinoma: the ImmunoTACE trial
Yuk Ting Ma, Jianmin Zuo, Amanda Kirkham, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
British Journal of Cancer
|
January 27, 2017
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion
Imam Waked, Sarah Berhane, Hidenori Toyoda, et al.
Nature Communications
|
December 23, 2022
Continuous cholinergic-dopaminergic updating in the nucleus accumbens underlies approaches to reward-predicting cues
Miguel Skirzewski, Oren Princz-Lebel, Liliana German-Castelan, et al.
Journal of Stem Cells & Regenerative Medicine
|
June 27, 2023
In Vivo Tumorigenicity of the 20q11.21 Amplicon in an Engraftment Model of hPSCs and Differentiated Liver Cells
Chris S Pridgeon, Shiva Seyed Forootan, Fang Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2014
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade
Philip J Johnson, Sarah Berhane, Chiaki Kagebayashi, et al.
British Journal of Cancer
|
February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
Natalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)
|
March 13, 2026
Dynamics in Circulating Proinflammatory Biomarkers for Prognostic Assessment of Patients With Advanced HCC - A Substudy From the SORAMIC Trial
Kerstin Schütte, Juozas Kupčinskas, Egidijus Morkunas, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 12, 2018
Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe
Muhammad Ahsan Javed, Georg Beyer, Nha Le, et al.
Journal of Hepatology
|
November 7, 2022
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study
Masatoshi Kudo, Richard S Finn, Shukui Qin, et al.
Cancers
|
September 13, 2025
UK Real-World Evidence of Using Durvalumab Plus Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer via an Early Access Scheme
Harry Daniels, Mona Hassan, Omer Babiker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2025
Addition of dendritic cell vaccination to conditioning cyclophosphamide and chemoembolisation in patients with hepatocellular carcinoma: the ImmunoTACE trial
Yuk Ting Ma, Jianmin Zuo, Amanda Kirkham, et al.
Page
of 11